Enovix CORP

Market Movers (8-K)

NASDAQ
Enovix Corporation announced the appointment of Dr. Michael Vyvoda, formerly of Apple, as its new Chief Operating Officer to lead global manufacturing and supply chain operations.
NASDAQ
Enovix Corporation stockholders approved the election of eight directors, executive compensation, and the appointment of Deloitte & Touche LLP at the 2026 Annual Meeting.
NASDAQ
Enovix Corporation announced the appointment of Steve Bakos as Senior Vice President of Worldwide Sales and an update on reaching alignment with its lead smartphone customer on a silicon-specific qualification framework.
NASDAQ
Enovix Corporation announced record fourth quarter and full year 2025 revenue, alongside significant progress in smartphone battery qualification and manufacturing readiness for high-volume production.
Capital raise
Worse than expected
Delay expected
NASDAQ
Enovix Corporation announced the retirement of its COO and a strategic leadership realignment to support mass production, alongside preliminary 2025 revenue growth of approximately 38%.
Better than expected
NASDAQ
Enovix Corporation reports strong Q3 2025 revenue growth and significant progress with its AI-1 battery technology and manufacturing expansion, backed by a strengthened balance sheet.
Delay expected
Better than expected
Capital raise

Quarterly Earnings (10-Q)

NASDAQ
Enovix Corporation reported an 85% increase in Q3 2025 revenue, driven by strong defense product demand, alongside strategic manufacturing expansion in South Korea and significant capital raises.
Delay expected
Capital raise
NASDAQ
Enovix Corporation announced a near doubling of quarterly revenue and significant progress in its AI-1 battery platform development and customer sampling, alongside a strategic South Korean manufacturing acquisition, despite reporting continued net losses.
Capital raise
Better than expected
NASDAQ
Enovix Corporation announces its Q1 2025 financial results, showcasing revenue of $5.1 million and progress in manufacturing readiness, product development, and a strategic acquisition in South Korea.
Capital raise
Worse than expected
NASDAQ
Enovix Corporation's Q3 2024 report details revenue growth, manufacturing advancements in Malaysia, and new strategic collaborations, while also noting ongoing restructuring costs and net losses.
Worse than expected
Capital raise
NASDAQ
Enovix Corporation announced its second quarter 2024 results, highlighted by a strategic shift in manufacturing operations and progress in product development.
Worse than expected
Capital raise
NASDAQ
Enovix Corporation reported its first quarter 2024 financial results, highlighted by a strategic realignment of manufacturing operations and a collaboration with Group14 Technologies.
Worse than expected
Delay expected
Capital raise

Annual Reports (10-K)

NASDAQ
Enovix Corporation filed an amendment to its annual report to correct an oversight in its auditor's consent, specifically adding references to certain S-3 registration statements.
Capital raise
NASDAQ
Enovix Corporation achieved its highest annual revenue and gross margins to date in fiscal year 2025, driven by defense shipments and significant progress in its AI-1 battery platform and manufacturing scale-up.
Delay expected
Capital raise
NASDAQ
Enovix Corporation details its FY2024 performance, highlighting manufacturing shifts and strategic market focus amid ongoing financial losses.
Worse than expected
Capital raise
NASDAQ
Enovix Corporation's 10-K filing reveals advancements in lithium-ion battery technology, strategic acquisitions, and a shift towards high-volume manufacturing in Asia.
Worse than expected
Delay expected
Capital raise

Insider Trading (Form 4)

NASDAQ
Arthi Chakravarthy, Chief Legal Officer of Enovix Corp, reported a transaction in 2,221 shares of common stock on July 24, 2026.
NASDAQ
Rajendra K Talluri, President and CEO and a Director of Enovix Corp, reported a transaction in 17,651 shares of common stock on July 18, 2026.
NASDAQ
Ryan A Benton, Chief Financial Officer of Enovix Corp, reported a transaction in 19,824 shares of common stock on July 14, 2026.
NASDAQ
Kristina Truong, Chief Accounting Officer of Enovix Corp, reported multiple transactions in common stock on July 10, 2026.
NASDAQ
Enovix Corp Chief Accounting Officer Kristina Truong reported a transaction involving the sale of 1,680 shares to cover tax obligations related to vested restricted stock units.
NASDAQ
Arthi Chakravarthy, Chief Legal Officer of Enovix Corp, reported transactions involving common stock and restricted stock units.

Proxy Statements (Def-14A)

NASDAQ
Enovix Corporation's 2026 Proxy Statement details 2025 operational progress, executive compensation structures, and upcoming annual meeting agenda.
Capital raise
NASDAQ
Enovix Corporation's recent shareholder presentation outlines its strategic focus on advanced silicon-anode lithium-ion batteries, global manufacturing expansion, and a performance-centric executive compensation structure, targeting smartphone launches in late 2025.
NASDAQ
Enovix Corporation has filed a definitive proxy statement with the SEC.
NASDAQ
Enovix sets sights on smartphone market entry by late 2025, highlighting manufacturing milestones and strategic partnerships in its latest proxy statement.
NASDAQ
Enovix releases a supplement to its proxy statement clarifying the employment arrangement with Dr. Raj Talluri and the circumstances surrounding the departures of former named executive officers.
NASDAQ
Enovix Corporation has filed a definitive proxy statement with the SEC.

Schedule 13D - Activist Investments

NASDAQ
Thurman J. Rodgers and affiliated trusts have increased their beneficial ownership in Enovix Corporation to 14.4% through recent share acquisitions, convertible note investments, and a significant warrant distribution.
Capital raise

Schedule 13G - Passive Investments

NASDAQ
The Vanguard Group reported a 0% beneficial ownership in Enovix Corp following an internal realignment, with subsidiaries now reporting holdings separately.